Company · Oxford
Nucleome Therapeutics Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Nucleome Therapeutics Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
- Dr Nadiya IshnazarovaDirector · since 2025
- Mark BodmerDirector · since 2024
- John DavisDirector · since 2024
- Dr Russell George GreigDirector · since 2023
- Dr Rana Abdul Raouf Al-HallaqDirector · since 2022
- Dr Bauke AnningaDirector · since 2022
- Dr Jonathan Paul HeppleDirector · since 2020
- James Raymond HughesDirector · since 2019
Previous officers 5
- Emma Johnson 2023-2025 View profile
- Dr Fiona Caroline Maclaughlin 2022-2025 View profile
- Dr Danuta Mariola Jeziorska 2019-2024 View profile
- Lachlan Tom Mackinnon 2019-2020 View profile
- Phil Boyd 2022-2024 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 17/07/2019
- Registered office
- Oxford
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- James Raymond Hughes ceased 2019-07-29
75-100% shares, 75-100% voting, appoints directors · notified 2019-07-17 - Oxford Science Enterprises PLC
25-50% voting · notified 2019-08-02
Group
- Nucleome Therapeutics Limited
is controlled by James Raymond Hughes
Evidence
ceased 75-100% shares, 75-100% voting, appoints directors · notified 2019-07-17, ceased 2019-07-29 · source: Companies House PSC register
Ultimately controlled by James Raymond Hughes.
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
8 directors on the board
- Dr Jonathan Paul Hepple Director · appointed 2020
- Dr Rana Abdul Raouf Al-Hallaq Director · appointed 2022
- James Raymond Hughes Director · appointed 2019
- Dr Bauke Anninga Director · appointed 2022
- John Davis Director · appointed 2024
- Dr Russell George Greig Director · appointed 2023
- Dr Nadiya Ishnazarova Director · appointed 2025
- Mark Bodmer Director · appointed 2024
Directors past 6 years
- James Raymond Hughes Director · appointed 2019
First-time vs portfolio directors
First-time (3)
- James Raymond Hughes Director · appointed 2019
- Dr Russell George Greig Director · appointed 2023
- Mark Bodmer Director · appointed 2024
Portfolio (5)
- Dr Jonathan Paul Hepple Director · appointed 2020
- Dr Rana Abdul Raouf Al-Hallaq Director · appointed 2022
- Dr Bauke Anninga Director · appointed 2022
- John Davis Director · appointed 2024
- Dr Nadiya Ishnazarova Director · appointed 2025
Left in the last 12 months
- Emma Johnson Director · appointed 2023 · resigned 2025
- Dr Fiona Caroline Maclaughlin Director · appointed 2022 · resigned 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 12109297
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data